Gus Alva

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia

Vincenzo S. Basile, Vural Özdemir, Mario Masellis et al. · Molecular Psychiatry · 2000 · 169 citations

Medicine, Genetics, Pharmacology +16

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Therapeutic Effects of Individualized Alpha Frequency Transcranial Magnetic Stimulation ( TMS) on the Negative Symptoms of Schizophrenia

Yi Jin, Steven G. Potkin, Aaron S. Kemp et al. · Schizophrenia Bulletin · 2005 · 141 citations · Full text

Life Sciences, Neuroscience, Psychiatry +16

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine

Steven G. Potkin, Vincenzo S. Basile, Yi Jin et al. · Molecular Psychiatry · 2003 · 114 citations

Medicine, Genetics, Pharmacology +14

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

Martin R. Farlow, Gus Alva, Xiangyi Meng et al. · Current Medical Research and Opinion · 2009 · 57 citations

Medicine, Pharmacology, Pharmacotherapy +17